Miami, FL, May 02, 2025 –(PR.com)– MindScape Retreat, a pioneer in clinical psychedelic therapy programs, has released the results of a transformative case series evaluating the safety and efficacy of a 14-day ibogaine treatment program for Parkinson’s disease. The findings suggest that ibogaine, a naturally occurring psychoactive alkaloid, may offer disease-modifying benefits in PD through its unique neuroregenerative properties.
Continue Reading → The study tracked 30 patients with idiopathic Parkinson’s disease (PD), ...